Study of visceral hypersensitivity in irritable bowel syndrome

Chinese Journal of Digestive Diseases

Volumn 5, Issue 3, 2004, Pages 103-109

  Dong, Wen Zhu ^a   Zou, Duo Wu ^a   Li, Zhao Shen ^a   Zou, Xiao Ping ^a   Zhu, Ai Yong ^a   Xu, Guo Ming ^a   Yin, Ning ^a   Gong, Yan Fang ^a   Sun, Zhen Xing ^a   Man, Xiao Hua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hypersensitivity; Irritable bowel syndrome; Mast cell; Substance P.

Indexed keywords

SUBSTANCE P;

ADULT; ANORECTAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEFECATION; DIARRHEA; ELECTRON MICROSCOPY; EMBEDDING; FEMALE; GASTROINTESTINAL MUCOSA; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; IRRITABLE COLON; MALE; MAST CELL; NERVE ENDING; NOCICEPTION; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; VISCERAL HYPERSENSITIVITY;

ADULT; CASE-CONTROL STUDIES; DEFECATION; FEMALE; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MAST CELLS; MIDDLE AGED; PAIN THRESHOLD; PERCEPTION; PRESSURE; RECTUM; SUBSTANCE P;

EID: 4444325352     PISSN: 14439611     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1443-9573.2004.00168.x     Document Type: Article

References (21)

1. Skaper SD. Nerve growth factor: a neurokine orchestrating neuroimmune endocrine functions. Mol Neurobiol 2001; 24: 183-99.
2. Bischoff SC, Mayer JH, Manns MP. Allergy and the gut. Int Arch Allergy Immunol 2000; 121: 270-83.
3. Gui XY. Mast cells: a possible link between psychological stress enteric infection food allergy and gut hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol 1998; 13: 980-9.
4. Monnikes H, Tebbe JJ, Hildebrandt M et al. Role of stress in functional gastrointestinal disorders: Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis 2001; 19: 201-11.
5. Suzuki R, Furuno T, Mckay DM et al. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol 1999; 163: 2410-15.
6. Drossman DA, Corazzian E, Talley NJ et al. Diagnostic criteria for functional gastrointestinal disorders. In: Drossman DA, Corazzian E, Talley NJ et al. eds. Rome II: the Functional Gastrointestinal Disorders, 2nd edn. Lawrence, KS: Allen Press, 2000; 659-68.
7. Zhijin G, ed. Selection of MC staining. In: The Section's Fabrication of Pathological Constitution, 1st edn. Shanghai: Shanghai Scientific Technique Press, 1994; 267-72.
8. Sabattini E, Bisgaard K, Ascani S et al. EnVision Plus system: Immunohistochemical method for diagnostics and research: Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998; 51: 506-11.
9. Wang JM, Zhang BZ. Light and electron microscopic study of the relationship of the substance P and vasoactive intestinal polypeptide immunoreactive nerve terminals with mast cells on meridian line in human skin. J Neuroanat 1986; 2: 79-84.
10. Sinhamahapatra P, Saha SP, Chowdhury A et al. Visceral afferent hypersensitivity in irritable bowel syndrome: evaluation by cerebral evoked potential after rectal stimulation. Am J Gastroenterol 2001; 96: 2150-7.
11. Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 2001; 93: 7-14.
12. Mertz H, Fullerton S, Naliboff B et al. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998; 42: 814-22.
13. Bouin M, Plourde V, Boivin M et al. Rectal distension testing on patients with irritable bowel syndrome: sensitivity, specificity and predictive values of pain sensory thresholds. Gastroenterology 2002; 122: 2075-8.
14. Chey WY, Jin HO, Lee MH et al. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol 2001; 96: 1499-506.
15. Weston AP, Biddle WL, Bhatia PS et al. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993; 38: 1590-5.
16. O'Sullivan M, Clayton N, Breslin NP et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000; 12: 449-57.
17. Kamm MA. The complexity of drug development for irritable bowel syndrome (Review). Aliment Pharmacol Ther 2002; 16: 343-51.
18. Yang Y, Zhou D, Zhang W. Mast cells of ileocecal junction in irritable bowel syndrome. Chung Hua Nei Ko Tsa China 1997; 36: 231-3.
19. Pang X, Boucher W, Triadafilopoulos G et al. Mast cell and substance P: positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis. Br J Urol 1995; 75: 154-61.
20. Stead RH. Innervation of mucosal immune cells in the gastrointestinal tract. Reg Immunol 1992; 4: 91-9.
21. Collin SM. Stress and the gastrointestinal tract. IV: Modulation of intestinal inflammation by stress: basic mechanisms and clinic relevance. Am J Physiol Gastrointest Liver Physiol 2001; 280: G315-18.